Institute of Human Biology and Evolution, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland.
Department of Pulmonology, Allergology and Respiratory Oncology, Poznan University of Medical Sciences, Poznan, Poland.
Nutrition. 2021 Sep;89:111221. doi: 10.1016/j.nut.2021.111221. Epub 2021 Feb 27.
The aim of this study was to describe the relationship between the prevalence of Pseudomonas aeruginosa (PA) and lung function, as well as the nutritional status and type of gene mutation in adult patients with cystic fibrosis (CF).
This cross-sectional study evaluated 103 Polish adults with CF the following: • The occurrence of PA and the level of bacterial susceptibility to antibiotics; • Type of mutation in the CFTR gene; • Nutritional status assessed by body mass index (BMI), and • Lung function measured by forced expiratory volume in 1 s (FEV1%).
The absence or presence of PA and the level of bacterial resistance were significantly related to the type of gene mutation (P < 0.001). In patients with a severe mutation, PA more often was extensively drug resistant or pandrug resistant compared with Pseudomonas culture-negative patients or patients with mild or unclassified mutations on both alleles. Associations were found between the presence of PA and lower values of BMI (P < 0.001), and FEV1% (P < 0.001). The risk for PA occurrence and the development of bacterial resistance increased twice in the case of severe mutation (odds ratio [OR], 2.51; 95% confidence interval [CI], 1.62-3.89), four times when BMI decreased <18.5 (OR, 4.15; 95% CI, 1.43-10.08). and six times when FEV1% fell <40 (OR, 6.75; 95% CI, 3.11-14.64).
The presence of PA is associated with lower FEV1% and BMI values. Deterioration of lung function, undernutrition, and severe type of gene mutation are linked to a higher probability of PA acquisition and resistance to antibiotic treatment.
本研究旨在描述铜绿假单胞菌(PA)的流行率与成人囊性纤维化(CF)患者的肺功能以及营养状况和基因突变类型之间的关系。
本横断面研究评估了 103 名波兰成年 CF 患者:①PA 的发生和细菌对抗生素的敏感性水平;②CFTR 基因突变类型;③通过体重指数(BMI)评估的营养状况,以及④通过 1 秒用力呼气量(FEV1%)测量的肺功能。
PA 的有无和细菌耐药水平与基因突变类型显著相关(P<0.001)。在严重突变的患者中,PA 更常为广泛耐药或泛耐药,而与假单胞菌培养阴性的患者或两个等位基因均为轻度或未分类突变的患者相比。PA 的存在与 BMI(P<0.001)和 FEV1%(P<0.001)较低值之间存在关联。在严重突变的情况下,PA 发生和细菌耐药发展的风险增加了两倍(优势比[OR],2.51;95%置信区间[CI],1.62-3.89),BMI<18.5 下降时增加了四倍(OR,4.15;95%CI,1.43-10.08),当 FEV1%下降<40 时增加了六倍(OR,6.75;95%CI,3.11-14.64)。
PA 的存在与较低的 FEV1%和 BMI 值相关。肺功能恶化、营养不良和严重的基因突变类型与 PA 获得和对抗生素治疗的耐药性增加的可能性更高相关。